KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Acquisitions (2016 - 2024)

Thermo Fisher Scientific's Acquisitions history spans 16 years, with the latest figure at $3.1 billion for Q3 2024.

  • For the quarter ending Q3 2024, Acquisitions rose 244.55% year-over-year to $3.1 billion, compared with a TTM value of $3.1 billion through Dec 2025, changed 0.0%, and an annual FY2025 reading of $4.0 billion, up 28.9% over the prior year.
  • Acquisitions for Q3 2024 was $3.1 billion at Thermo Fisher Scientific, up from $909.0 million in the prior quarter.
  • The five-year high for Acquisitions was $17.9 billion in Q4 2021, with the low at -$1.0 million in Q2 2020.
  • Average Acquisitions over 5 years is $2.0 billion, with a median of $82.0 million recorded in 2021.
  • Year-over-year, Acquisitions crashed 101.06% in 2022 and then soared 91000.0% in 2023.
  • Tracing TMO's Acquisitions over 5 years: stood at $35.0 million in 2020, then skyrocketed by 50974.29% to $17.9 billion in 2021, then tumbled by 100.01% to -$1.0 million in 2022, then soared by 91000.0% to $909.0 million in 2023, then skyrocketed by 244.55% to $3.1 billion in 2024.
  • Per Business Quant, the three most recent readings for TMO's Acquisitions are $3.1 billion (Q3 2024), $909.0 million (Q3 2023), and $47.0 million (Q3 2023).